Cohort studies are common in clinical and epidemiological research. Participants in cohort studies are grouped by the presence or absence of an exposure of interest, and followed to determine if the risk of developing an outcome or disease differs between exposed and unexposed. Because exposures are not randomly assigned, it can be difficult to determine whether observed associations are due to an exposure itself, or to other differences between exposed and unexposed participants. As with other study designs, a clearly defined research question and a publically available protocol document can increase the validity of results (BJOG 2018; https://doi.org/10.1111/1471-0528.15196).
A cohort study may be useful when, for practical or ethical reasons, a randomised trial is not feasible. Prospective cohorts that seek to explain the causes of a disease may require numerous participants to be followed for many years. For example, to determine whether ovarian inclusion cysts are associated with ovarian, breast or endometrial cancer, investigators enrolled 48 240 women from an ovarian cancer screening trial (Sharma et al., BJOG 2012; 119:207-19) . They identified an exposed group (women with inclusion cysts) and an unexposed group (women with normal ultrasound results), and followed them for a median of 6 years. After ascertaining cancers in each group, the investigators compared adjusted (for known confounders) rate ratios and standardised incidence rates, and found no evidence of any associations.
Large prospective cohort studies are often more definitive than retrospective ones. However, retrospective cohort studies, which use existing data (reducing time and cost) such as medical records and disease registries, are common in clinical research. In a recent retrospective cohort, investigators used cancer registry data to compare survival between women with lymph-node-positive serous endometrial cancer who were treated with chemotherapy alone or chemotherapy and radiotherapy (Lin et al., BJOG 2016; 123:1846-52) . Although survival outcomes occurred before the study was initiated, the logic of the study is the same: the investigators used the database to define a cohort of exposed (received chemotherapy and radiation) and unexposed (received chemotherapy only) patients, and to determine their subsequent outcomes (survival). The investigators again adjusted for known confounders, and found that treatment with chemotherapy and radiation was associated with longer survival compared with chemotherapy alone.
The possibility that associations identified in observational cohort studies result from confounding poses a challenge to concluding that such associations reflect causeand-effect relationships. Although statistical methods can adjust for measured differences between exposed and unexposed participants, other important differences may be unmeasured. For example, if patients with a good prognosis received chemotherapy and radiotherapy whereas those with a poor prognosis received chemotherapy alone, the observed association with survival could reflect underlying differences in patient and disease, rather than a causal effect of the treatment.
Useful resources
The STROBE statement provides useful guidance on reporting of cohort studies, available at: https://strobe-statement.org.
A BJOG commentary gives a detailed explanation about hidden biases in observational epidemiology: Ananth et al., BJOG 2018; 644-6. 
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